• 专利附录
  • 专利说明
  • 权利要求
  • 类似技术
  • 同族专利
  • 引用文献
  • 法律状态
  • 优先权
    • 专利摘要:
    A novel Antibiotic C-15003 P-4 is specifically produced by cultivating a microorganism of the genus Nocardia in a culture medium containing leucine and/or its derivatives. The Antibiotic C-15003 P-4 is useful as an antifungal agent, antiprotozoan agent and antitumor agent.
    公开号:SU882414A3
    申请号:SU782691551
    申请日:1978-11-16
    公开日:1981-11-15
    发明作者:Хигасиде Еидзи；Хатано Казунори；Асаи Мицуко
    申请人:Такеда Кемикал Индастриз,Лтд (Фирма)；
    IPC主号:
    专利说明:

    (5) METHOD OF OBTAINING ANTIBIOTIC C-15003 R-
    one
    This invention relates to microbiology and concerns the manufacture of antibiotics.
    The proposed antibiotic is new and the method for its preparation is not described in the patent and scientific literature.
    The aim of the invention is to obtain an antibiotic.
    This goal is achieved by the fact that the strain
    Nocardia sp.NC-15003 (AJCC-31281, 3FO-13726) is grown in a nutrient medium containing sources of carbon and nitrogen, with the addition of leucine or its derivatives.
    Strain Nocardia sp. NC-15003, an antibiotic-producing, was isolated from soil and other samples.
    The NC-15003 strain is deposited at the Agency of Industrial Science and Technol ogy (PERM) Fermentation Research Institute (PERM) number 3992, at the Fermentation Institute, Osaka (JFO) under JFO number 13726, and in the American Type Variety Collection (ATCC), Maryland, USA under number 31281.
    Cultural and morphological features. The vegetative mycelium grows 6 well, the hyphae reach 0.8-1.2 µm in diameter, in some cases they can be divided into fragments. Aerial mycelium is superimposed on the vegetative mycelium, often forming
    10 monoliths (50-200X200-1000 µm), on which further growth continues. Aerial mycelium is a wave-like, straight or loop-like helix. Microscopic examination of old cultures shows that only in a few cases conidia are formed in the chains as cells, whereas cell suspensions obtained from the surfaces of such cultures
    20 contain many elongated ellipsoidal (0.8-1.2 μm X, 8-6.8 μm) and ellipsoidal (0.8-1.2 x.: 1.02, 0 μm) Taurus, similar to arthrospores
    Saccharose-nitrate agar: growth is moderate, the color of the melon is up to tan tan, forms a body similar to monoliths. Aerial mycelium scanty, white. Soluble pigment is absent or pale yellowish-tan, Glycerin-nitrate agar: substrate mycelium - growth is moderate, ivory-colored, forms bodies similar to monoliths. Aerial mycelium moderate, white. Growing pigment is missing. Glucose-aspartic agar: grew moderate, calendula-colored to yellow. Aerial mycelium scanty, white. Soluble pigment is bright yellow. Glycerin-aspartic agar: moderate growth, ivory-colored, forms bodies similar to monoliths. Aerial mycelium scanty, white. Soluble pigment is missing. Starch agar: moderate growth, light ivory to light wheat, forms bodies similar to monoliths. Airy Lice is abundant; light ivory. Soluble pigment is missing. Agzr on oats: moderate growth, color from light ivory to colonial yellow, forms bodies similar to GUNoliths. Aerial mycelium is scanty, from white to light yellow, Soluble pigment is absent, Tyrosine agar: moderate growth, from light ivory to light yellow melon, forms bodies similar to monolith. Aerial mycelium is moderate, from white to bright light ivory. Dissolvable pigment color camel. Physiological signs. The temperature range of growth is 12-38 ° C. The temperature range in which good air growth is observed is 20-35 ° C. Gelatine liquefies. Starch hydrolyzes. Nitrates restores. Peptonized milk, but does not coagulate. Casein disintegrates. Melanoid pigments on agar with peptone and yeast extract does not produce, on tyrosine agar produces. Tyrosine decomposes, Xanthine and hypoxanthine does not rend. Tolerance of liaozyme is positive. Chlorine tolerance to sodium is 2%. It grows well on fructose, mannose, grows well on glucose, mannitol, sucrose, soluble starch. It absorbs xylose, arabinose, galactose, rhamnose, trehalose, raffinose, melibiose, poorly absorbs maltose, glycerin, does not absorb i-inositol, D-sorbitol, lactose. Leucine as an additive can be used in the form of a derivative. Examples of the derivative are C-C alkyl esters, for example methyl ester, leucine ethyl ester, amides such as C-C amide alkylamides (for example, N-methylamide, Nethylamide) of leucine, its keto acids (for example, L-keto-isocaproic acid) or salts such as hydrochlorides. Preferably with the C-form of leucine. The free form of leucine and its derivatives and the mixture of derivatives are also applicable. The amount of substance added to the medium is 0.0.1 - 1% w / v, preferably 0.1 - 0.5. The time of addition is any during the production of P- antibiotic, preferably added at the beginning of the cultivation stage. The antibiotic culture medium may contain carbon and nitrogen sources, inorganic substances, nutrient traces. Glucose, lactose, sucrose, maltose, dextin, starch, glycerin, mannitol, sorbitol, fats and oils (for example, oil from beans, soy, lard, chicken fat) are used as carbon sources. As nitrogen sources, use is made of meat extract, yeast extract, dry yeast, soy flour, liquid from soaked grains, cotton seed peptonic flour, molasses, urea, ammonium salts (for example, ammonium sulfate, ammonium chloride, ammonium nitrate) and salt nitrate (for example sodium nitrate, potassium nitrate). The medium may also contain salts of sodium, potassium, calcium, magnesium, salts of iron, manganese; zinc, cobalt, nickel, salts of phosphoric acid, boric acid. The medium may contain vitamins as additives (for example, Bg, Bg, nicotinic acid, Bc, C, E), nucleic acids (for example, purine, pyrimyl, din and their derivatives).
    Inorganic or organic acids, alkalis, buffer solutions are added to establish the desired pH of the medium. As antifoam agents, suitable amounts of oils, fats, surfactants are added.
    Cultivation is carried out in any stationary, with shaking, aerobic immersion and other conditions for growing crops. For high yields, aerobic immersion of the culture is preferred.
    Incubation is carried out at a temperature of 20-35 ° C with an initial pH of 5.5-8.5, preferably between 23-30 ° C and pH 6.5-7.5.
    82tl 6
    Incubation time can be 8-240 hours.
    An antibiotic is obtained as follows.
    5 Strain NC-15003 is grown in medium 1 containing 3% soluble starch, 0.2 ammonium chloride, 0.05 magnesium sulfate, Ij09% potassium dihydrate phosphate, 2.09% dipotassium 10 acidic phosphate, 0.001% ferrous sulfate and additional substances, or in culture medium (I, containing 5% dextrin, 3% liquid from soaking. grain, 0.1% peptone, 0.5% carbonate 15 calcium and additional substances, and. then this medium is cultivated. The results obtained for medium T, are shown in Table 1, and the results obtained for the medium | are listed in Table 2.
    20
    Table 1
    -che
    (Q.) in the Add Time column means that the substance is added as one of the ingredients.
    The determination of the obtained P-2, P-3 and P-4 is carried out as follows.
    Table 2
    Nutrient broth is extracted with an equal volume of ethyl acetate. The solvent solution layer is concentrated and dried, then dissolved with ethyl acetate to obtain 1/100 volume of the starting broth. Products are determined by thin layer chromatography on silica gel using a saturated aqueous solution of ethyl acetate. The resulting quantity and component ratio are determined by the absorbance value on a C5-910 long-fiber TLC-multipoint measuring device based on the integral densities of each spot on the chromatogram at 25 mm. The ratio of components is presented in percent weight / weight in total products, P-2, P-3, P-. As shown in the table. 1 and 2 strain NC-15003 produces antibiotic PA in the amount of b5-8A% of the total amount in the presence of specific additives, and 25 or less in the absence of such additives. Therefore, the release of P from nutrient broth is more efficient in the first case than in the second. Since the Pt obtained in this way in a fermentation liquid medium is a lipophilic neutral substance, it is usually isolated from the nutrient broth in accordance with the isolation and purification methods that are commonly used to isolate such microbial metabolites, PA is easily extracted from the nutrient broth. filter water-immiscible organic solvents, such as esters of fatty acids, such as ethyl acetate and amyl acetate, alcohols, such as butanol, halogenated hydrocarbons, such as chloroform, ketr Such as methyl isobutyl ketone. Extraction of P- is carried out at a pH close to neutral, and preferably extracted with ethyl acetate, the pH of which is 7. The extract is washed with water and concentrated under reduced pressure. A non-polar solvent, for example petroleum ether or hexane, is then added to the concentrate and the crude product containing the active compound is isolated as a precipitate. The resulting crude product is, if desired, subjected to conventional purification methods. Thus, adsorption chromatography can be used as an 8 standard purification method. For this purpose, one of the commonly used adsorbents is used, for example, silica gel, alumina, macroporous non-ionic resins, adsorbents, and so on. P-in the crude product is separated on such a silica gel chromatograph, for example, using petroleum ether and hexane and. the elution is carried out by adding a polar solvent such as ethyl acetate, acetone, ethanol or methanol, or halogenated hydrogen, such as dichloromethane or chloroform with the addition of a polar solvent, such as an alcohol, for example methanol or ethanol, ketone, for example acetone or methyl ethyl ketone, or the like. In this way, P-t can be eluted, isolated and obtained. If the adsorbent is used as a cleaning agent as a macroporous resin, the elution is carried out with a mixture of water with a lower alcohol, a lower ketone or an ester. For example, the lower alcohol may be methanol, ethanol, propanol or butanol, the lower ketone may be, for example, acetone methyl ethyl Silkketone, As the ester may be ethyl acetate, butyl acetate. The crude product (1 is dissolved in 60 mixtures of methanol and water and adsorbed on a Dialon HP-1 column. The column is washed with 701 methanol-water mixture. Then elution is performed with methanol-water. The fractions containing P-4 are collected and concentrated 5-8 volumes of ethyl acetate are added to the dry product, and the mixture is allowed to stand, after which P. crystals are separated. The antibiotic yield reaches about b5 or more, and the proposed method is easily mainly for pr Thinking obtain P-4. Physicochemical properties Rprivedeny in Table 3.
    Antibiotic
    Formula
    Melting point, ° C
    Specific rotation
    110
    Idl
    Elementary analysis
    Found%
    Elementary analysis
    Calculated%
    Ultraviolet Absorption Spectrum HM (6)
    (in methanol)
    Infrared absorption spectrum KBG, cm
    NMR spectrum of particles per million, 100 Mg in DM "s
    Mass Spectrum (t / e) Solubility
    Color reaction
    8821411 10
    Table 3
    C-15003 P-
      , 196
    177-180 W2 i 10 with 0.522 CHCl j)
    From 60.65
    H 7.05
    N 4.25
    C 5.23
    C 61, 05
    H 6.99
    N (4.32
    about
    C1 5.6
    233 (29900) (shoulder) 252 (275590;
    280 (5712) 288 (5680)
    , 1730.1670.1580,
    , 1385,, 1255,
    Air Defense, 1150,1100,1080, 1038
    1.03 (d) (6H) 587 ,, A70, 450
    Insoluble in petroleum ether, hexane, water. Moderately soluble in benzene, ether. Soluble in chloroform, ethyl acetate, acetone, ethanol, methanol, pyridine, tetrahydrofuran, dimethyl sulfoxide
    Dragendorf: Positive Belstein: Positive
    Antibacterial activity By the method of paper disks, inhibiting concentrations of a strain grown on trypticose-soybean agar (BBL) against microorganisms listed below are determined. Thus, discs of filter paper impregnated every 0.02 (1 L solution of 300 µg / ml solution are placed on plates inoculated with microorganisms listed below, respectively, to determine the minimum inhibitory concentration. The results showed that antibiotics are not active against the following microorganisms: Escherichla coli, Proteus vulgaris, Proteus mirabllis, Pseudomonas aeruginosa, Staphylococcu ureus, Vasp lus subtil is Bacillus cereus, Klebsiella pneumoniae, Serratia marcescens, Mycobacteriurn avium.
    On the other hand, on agar plates containing the test medium (3.5 g of disodium phosphate, 0.5 g of monopotassium phosphate, 5 g of yeast extract (Difco), 10 g of glucose, 15 g of agar, 1000 ml of distilled water, pH) Growth Talaromyces avellaneus. In this experiment, the minimum inhibitory concentration is 1-1.5 µg / ml for P-. Next, wild strain Tetrahymenpyrlformisis w is cultivated as a test organism on a test environment, consisting of 20 g of proteose-peptone (DIfco) 1 g of yeast extract, 2 g of glucose 1000 ml of distilled water and 10 ml of 1 M phosphate buffer pH 7.0 j for kk 48 h and the growth inhibition activity of antibiotics against this particular microorganism is determined by the method of successive dilutions. Growth inhibition was found to be observed at a concentration of 0.5 µg / ml for C-15003 P-.
    P-k has activity against the following microorganisms: Faslcladium levieri, Helminthosporiu sigmoideum var, irregulare, Pyricularla oryzae, Cochlicborus miyabeanus, Sclerotinia sclerotiorum Pellicularia sasakii, Trichophyton. rubrum, Rhodotorula rubra and Cryptococcus neoformans.
    Antitumor activity. The therapeutic effect of P-administered intraperitoneally for 9 consecutive days, against leukemia P388 in mice (1x10 cells / animal transplanted intraperitoneally) was investigated. The results showed that, in terms of the degree of prolongation of life, these compounds have an anti-tumor activity of about 200 at a dose level of 0.00625 mg / kg per day.
    Toxicity. In the acute toxicity test that was performed on mice as experimental animals, which included intraperitoneal injections of R-C, all the antibiotics studied demonstrated an LD | oo value of 050.625 mg / kg and an LDO of 0.313 mg / kg.
    Antibiotic P-k has a high inhibitory activity against fungal organisms and protozoa and is therefore valuable as a fungicidal agent or agent against protozoa. In addition, since P-k exhibits a prolonged lifespan in mammals that have a tumor (for example, mice), you can also expect this compound to be used as an antitumor medication.
    As a fungicide or agent, protozoa P-4 can be used to evaluate bacterial ecology in soil, activated sludge, animal fluids, etc. So, if you need to isolate valuable bacteria from soil samples or if you want to evaluate
    0 the action of bacteria, regardless of the fungal or protozoa during the work and the study of active silt systems used for wastewater treatment, you can use
    5 an antibiotic for obtaining the selective growth of a bacterial flora, accompanied by the suppression of the growth of contaminating fungal or protozoa organisms in a sample. In that
    In the event that a sample is added to a liquid or solid medium and 0.1 ml of a solution of 10100 µg / ml of antibiotic in methanol-water is added to 1 ml of medium, after which the sample
    5 incubated.
    P- can also be used in. as a bactericidal agent for controlling plant diseases caused by the microorganisms mentioned above. As a typical case, P is used as a 1% methanol aqueous solution containing 0.5 μg / ml - 5 μg / ml antibiot. For example, P-4 can be used to control reddish-brown leaf rot, blast, helmintosporia ppnostyu leaves and leaf disease of rice plants. Example 1. AO ml of a seed culture medium (1.0% glucose, 2.0% bactotrypton, 1.2% bact yeast extract, pH 7.0) were poured into a 200 ml Erlenmeyer flask. After sterilization on Wednesday 1. incubate Nocardia sp. C-15003 (JFO 13726: ATCC 31281: FERM 3992 Inoculum nt is incubated at 28 ° C in a rotating shaker (200 rpm) to obtain a seeded culture. This seedling is washed three times with sterilized distilled water and the washing cells are harvested the initial amount of sterilized distilled water. 1 ml of the obtained substance is inoculated into the main culture medium of soluble starch, 0.2 ammonium chloride, 0.05 magnesium sulfate, 0.09% monopotassium phosphate, 2.09 dipotassium phosphate 0.001% ferrous sulfate, 0.3% L-leucine, and the main culture medium in Kept at 28–8 days in a rotating shaker (200 rpm). The total amount of C-15003 obtained is 12 µm / m and 80% of it is R-m. Example 2, Prepare the same cultures, as in example 1, and 500 ml of the seed culture were poured into a 2000 ml Sakagushi flask. After sterilization, the culture medium was inoculated with the same strain as in example 1. The inoculated medium was cultured at A8 hours with rotational-translational motion (110 stroke / min) until sowed culture is obtained. 100 liters of seeded culture (2.0% glucose, 3.0% soluble starch, 1.0% soaked grain liquid, 1.0% soy flour, 0.5% polypeptone, 0.3% sodium chloride, 0.5 % calcium carbonate, pH 7.0} is prepared and poured into a 200-liter stainless steel fermenter.After the fermenter is sterilized at 12 ° C for 20 minutes and cooled with C14, it is inoculated with 500 ml of a seeded culture. The content is cultured at 28 ° C for 8 hours at a speed of aeration of 100 l / min, stirring speed of 200 rpm. Nutrient broth (Eul) is placed in 100 liters of nutrient medium (5% dextrin, 3% of the liquid is soaked grains, 0.1% peptone, 0.5 L leucine, 0.5% calcium carbonate, pH) in a 200-liter stainless steel fermenter, the fermentation is carried out for k dy at aeration rate of 100 l / min and a stirring speed of 150 / The total amount of C-1S003 obtained is 12 µg / ml, and the R-C of C-15003 is about 85% (w / w 4. Example 3) To 50 l of the nutrient medium obtained in Example 2 is added 50 l of acetone. The mixture was stirred for 30 minutes. To the mixture was added 2 kg of hyflo-supercell and the mixture was mixed well. The resulting mixture is filtered on a filter under pressure, resulting in a gain of 13.5 l of filtrate. 50 L of water and 90 L of ethyl acetate are added to the obtained filtrate, the mixture is stirred and extracted. The procedure is repeated twice. The resulting ethyl acetate layers were combined and washed twice with 80-liter portions of water. 1 kg of anhydrous sodium sulfate is added to the layer, dried and concentrated to 200 ml. Petroleum ether was added to the resulting concentrate, and the precipitate formed was collected by filtration to give 35 g of product. 50 ml of ethyl acetate was added to the crude product thus obtained, and the mixture was stirred. The insoluble part was isolated by filtration, and 10 g of silica gel was added to the filtrate. After the resulting mixture was stirred, the ethyl acetate was distilled off under reduced pressure. The residue is placed on top of a silica gel column (500 ml). Zlyuirovanie. 500 ml of g-hexane, 500 ml of a mixture of i-hexane: ethyl acetate (3: 1), 2000 ml of a mixture of n-hexane: ethyl acetate (1: 1), and 2000 ml of a saturated aqueous solution of ethyl acetate. When this eluate is collected in 50-ml fractions. 1 ml from each fraction was concentrated to dryness and 0.1 ml of ethyl acetate was added to the resulting concentrate to form a mixture. The mixture gives a spot at a distance of 2.5 cm from the bottom edge of the silica gel-glass plate and appears about 17 cm in solvent (water, saturated with ethyl acetate). After the appearance, ultraviolet radiation (2537 A) is determined. Active fractions of Rf 0.9 are collected and concentrated at PONY "ANOM pressure ml. To this are added 20 ml of petroleum ether,, | H | resulting in 1.0: 8 crystals. The crude crystals are dissolved in 20 ml of warm ethyl acetate. Irsle cooling allocates 920 mg. P-crystals. The temperature of the board is 178-18 (3 C (P-, 9 weight / weight). Example. 20 g of the crude product obtained in Example 3 is dissolved in 400 ml of 501 methane methanol. A column of 2.5 cm in diameter is filled with 1000 ml , Diapion HP-10 and prepare 3000 ml of a mixture of methanol-water. The sample solution prepared in this way is passed through a column and washed using 1000 ml of 60% methanol and successively carried out. Gradient elution of 7500 ml of methanol-water, 7500 ml methanol-water mixtures. The eluate is collected in 75 ml fractions and each fraction is examined by thin-layer chromatography on silica gel, In Example 3. Fractions NN 182-190 were collected and concentrated, 500 ml of water and 1000 ml of ethyl acetate were added to the concentrate, the solution was shaken in a separatory funnel and the aqueous layer was separated, after washing twice with 300 ml of ethyl acetate the layer is dried over anhydrous sodium sulphate, concentrated and left to stand, the result is crystals that are collected by filtration and dried. 950 kg of P-k are obtained. Melting point 177-179 ° C (P-, 92% w / w). PRI me R 5. Using the procedure of Example 1, but using leucine methyl ester instead of L-leucine. Leucine N-methylamide, oC - chum zocagronic acid or leucine hydrochloride, get the same result, namely, they receive specifically required P-. The proposed method allows to obtain a new antibiotic C-15003 P. The formula of the invention. A method for producing an antibiotic C-15003 P-4, characterized in that the Nocardia ar NC-15003 strain (ATCC-31281, JFO 13726) is grown in a nutrient medium containing carbon sources and nitrogen with the addition of leucine or its derivatives. Sources of information taken into account in the examination of the proposed new antibiotic and the method of its production in the patent and scientific literature is not described.
    权利要求:
    Claims (1)
    [1]
    Claim
    The method of producing the antibiotic C-15003 P-4 characterized in that the strain Nocardia ar NC-15OO3 (ATCC-31281, JFO 13726) is grown in a nutrient medium containing carbon and nitrogen sources with the addition of leucine or its derivatives.
    类似技术:
    公开号 | 公开日 | 专利标题
    US4360462A|1982-11-23|Process for preparing maytansinol
    WO1987006265A1|1987-10-22|Novel compounds dc-88a and dc-89a1 and process for their preparation
    Hayashi et al.1982|Cyanocycline A, A new Antibiotic Taxonomy of the Producing organism, Fermentation, Isolation and Characterization
    SU1036251A3|1983-08-15|Process for preparing antibiotic c=15003 p-3
    EP0031430B1|1983-12-28|A method for the production of antibiotic c-15003 p-3
    CA1054959A|1979-05-22|Rifamycins from nocardia mediterranea
    US4187292A|1980-02-05|Antibiotics produced from the microorganism nocardice
    SU882414A3|1981-11-15|Method of preparing c-15003 p-4 antibiotic
    ONISHI et al.1984|A MACROCYCLIC ANTIBIOTIC M-230B PRODUCED BY MYXOCOCCUS XANTHUS ISOLATION AND CHARACTERIZATION
    US4551533A|1985-11-05|Antibiotic LL-D42067α
    NL8001868A|1980-10-06|COMPOUNDS WITH ANTITUMOR AND ANTIBACTERIAL EFFECT; METHOD FOR PREPARING THEREOF PREPARATIONS WITH ANTITUMOR AND ANTIBACTERIAL EFFECT.
    US4540517A|1985-09-10|Antibiotic TAN-420
    US5320955A|1994-06-14|10'desmethoxystreptonigrin production by Streptomyces albus
    US6121310A|2000-09-19|Aflatoxin contamination inhibitor and aflatoxin contamination-inhibiting method
    US4686308A|1987-08-11|Novel physiologically active substance MH435
    CA1236785A|1988-05-17|ANTIBIOTIC LL-D42067.beta.
    EP0206138B1|1989-03-08|Anthracycline compounds, a process for their preparation and their use as medicaments
    US5109133A|1992-04-28|Antibiotic trienomycins and their production
    US4292309A|1981-09-29|Antibiotics C-14482 B1, B2 and B3
    US5334613A|1994-08-02|Antibacterial substance BE-24566B
    CS214749B2|1982-05-28|Means for treating the diseased plants and method of preparation of active substance
    HU202284B|1991-02-28|Process for producing new azoxy derivatives and pharmaceutical compositions comprising same as active ingredient
    SU741804A3|1980-06-15|Method of preparing antibiotic
    EP0259778B1|1990-03-28|Antibiotically effective gentisine acid derivative
    US4730039A|1988-03-08|Leucanicidin
    同族专利:
    公开号 | 公开日
    US4229533A|1980-10-21|
    FR2409306A1|1979-06-15|
    DK514478A|1979-05-19|
    DE2849666A1|1979-05-23|
    IT7829921D0|1978-11-17|
    GB2011384B|1982-05-19|
    IT1160087B|1987-03-04|
    FR2409306B1|1981-03-06|
    PL122365B1|1982-07-31|
    JPS6010720B2|1985-03-19|
    GB2011384A|1979-07-11|
    CH640269A5|1983-12-30|
    ES475179A1|1979-05-16|
    DK144658B|1982-05-03|
    JPS5473193A|1979-06-12|
    NL7811324A|1979-05-22|
    DK144658C|1982-11-22|
    PL211027A1|1979-07-02|
    HU179599B|1982-11-29|
    引用文献:
    公开号 | 申请日 | 公开日 | 申请人 | 专利标题
    US3902968A|1974-04-25|1975-09-02|Merck & Co Inc|Fermentation process|
    JPS58876B2|1975-11-19|1983-01-08|Fujisawa Pharmaceutical Co|
    JPS6010718B2|1977-03-31|1985-03-19|Takeda Chemical Industries Ltd|
    FR2385714B1|1977-03-31|1982-05-14|Takeda Chemical Industries Ltd|
    US4162940A|1977-03-31|1979-07-31|Takeda Chemical Industries, Ltd.|Method for producing Antibiotic C-15003 by culturing nocardia|
    US4151042A|1977-03-31|1979-04-24|Takeda Chemical Industries, Ltd.|Method for producing maytansinol and its derivatives|JPS55162791A|1979-06-05|1980-12-18|Takeda Chem Ind Ltd|Antibiotic c-15003pnd and its preparation|
    JPS6253158B2|1979-09-19|1987-11-09|Takeda Chemical Industries Ltd|
    JPS6316120B2|1979-12-28|1988-04-07|Takeda Chemical Industries Ltd|
    GB8712752D0|1987-05-30|1987-07-01|Tioxide Group Plc|Particulate material|
    GB8829402D0|1988-12-16|1989-02-01|Tioxide Group Plc|Dispersion|
    CN102586153A|2012-03-06|2012-07-18|福州大学|Method for carrying out high-density culture on bacillus subtilis|
    法律状态:
    优先权:
    申请号 | 申请日 | 专利标题
    JP52139384A|JPS6010720B2|1977-11-18|1977-11-18|
    [返回顶部]